Comparison of warfarin, dabigatran, rivaroxaban and apixaban for effectiveness and safety among elderly patients with atrial fibrillation: a nationwide cohort study
Event:
ESC Congress 2020
Topic:
Oral Anticoagulation
Session:
Oral Anticoagulant Therapy in the Elderly with Atrial Fibrillation